0001708138-21-000068.txt : 20210831
0001708138-21-000068.hdr.sgml : 20210831
20210831160300
ACCESSION NUMBER: 0001708138-21-000068
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210827
FILED AS OF DATE: 20210831
DATE AS OF CHANGE: 20210831
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: POON CHRISTINE A
CENTRAL INDEX KEY: 0001189014
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 211227022
MAIL ADDRESS:
STREET 1: C/O JOHNSON & JOHNSON
STREET 2: ONE JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2021-08-27
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001189014
POON CHRISTINE A
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2021-08-27
4
M
0
15000
57.11
A
16681
D
Common Stock
2021-08-27
4
S
0
100
662.62
D
16581
D
Common Stock
2021-08-27
4
S
0
2260
663.51
D
14321
D
Common Stock
2021-08-27
4
S
0
700
664.42
D
13621
D
Common Stock
2021-08-27
4
S
0
538
665.33
D
13083
D
Common Stock
2021-08-27
4
S
0
1118
666.7
D
11965
D
Common Stock
2021-08-27
4
S
0
2150
667.37
D
9815
D
Common Stock
2021-08-27
4
S
0
603
668.33
D
9212
D
Common Stock
2021-08-27
4
S
0
2235
669.59
D
6977
D
Common Stock
2021-08-27
4
S
0
3447
670.48
D
3530
D
Common Stock
2021-08-27
4
S
0
1737
671.49
D
1793
D
Common Stock
2021-08-27
4
S
0
112
672.27
D
1681
D
Non-Qualified Stock Option (right to buy)
57.11
2021-08-27
4
M
0
15000
0.0
D
2022-01-03
Common Stock
15000
0
D
Represents volume-weighted average price of sales of 2,260 shares of Company stock on August 27, 2021 at prices ranging from $663.11 to $663.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 700 shares of Company stock on August 27, 2021 at prices ranging from $664.00 to $664.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 538 shares of Company stock on August 27, 2021 at prices ranging from $665.07 to $665.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,118 shares of Company stock on August 27, 2021 at prices ranging from $666.39 to $666.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 2,150 shares of Company stock on August 27, 2021 at prices ranging from $667.01 to $667.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 603 shares of Company stock on August 27, 2021 at prices ranging from $668.04 to $668.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 2,235 shares of Company stock on August 27, 2021 at prices ranging from $669.17 to $669.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 3,447 shares of Company stock on August 27, 2021 at prices ranging from $670.01 to $670.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 1,737 shares of Company stock on August 27, 2021 at prices ranging from $671.00 to $671.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
Represents volume-weighted average price of sales of 112 shares of Company stock on August 27, 2021 at prices ranging from $672.27 to $672.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 27, 2021 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
/s/**Christine A. Poon
2021-08-31